The Long‐Term Clinical Outcomes of Triple‐Frequency Ultrasound in Treatment of Cellulite
Journal of Cosmetic Dermatology · 2026-11 · 25 (11)
DOI: 10.1111/jocd.71292 ↗Abstract
ABSTRACT Objectives In this non‐interventional case‐series follow‐up study, we investigated the long‐term outcomes of triple‐frequency LDM (TF‐LDM) ultrasound in treatment of cellulite. Methods Fourteen Caucasian women with mild‐to‐severe gynoid lipodystrophy were included in this study. All participants underwent long‐term follow‐up (LTFU) assessments between 17.0 and 32.5 months after treatment, and the obtained results were compared with the corresponding values at baseline, on the day of the last treatment, and at the intermediate follow‐up (IFU). Cellulite severity at LTFU was assessed by eight independent clinicians using the five‐grade Clinician‐Reported Photonumeric Cellulite Severity Scale (CR‐PCSS). Participant satisfaction was evaluated using the 11‐point Global Aesthetic Improvement Scale (GAIS). Thirteen participants also underwent B‐mode ultrasonography and real‐time compression elastography to objectively assess treatment outcomes by determining the elastic scores of the dermis and skin‐associated adipose tissue (SAAT) using a five‐grade color scale. Results The mean value of CR‐PCSS score for the 14 participants at LTFU was 1.65 ± 0.85, compared with 2.30 ± 0.90 at baseline, 1.25 ± 0.86 on the day of the last treatment, and 1.04 ± 0.92 at IFU, respectively. Treatment outcomes continued to improve after the final TF‐LDM treatment session, and the clinical benefits remained evident for at least 22 months compared with baseline. Elastic scores increased significantly from baseline to IFU in both the dermis and SAAT. In the dermis, a slight but statistically significant reduction in elastic scores was observed at LTFU compared with IFU, whereas no statistically significant difference between IFU and LTFU was detected in the SAAT. The mean participant satisfaction score at LTFU was 9.29 ± 0.83. No treatment‐related side effects were reported during the treatment course, at IFU, or at LTFU. Conclusions TF‐LDM is an effective, well‐tolerated, and well‐accepted treatment for cellulite that provides significant long‐term clinical improvement without treatment‐related side effects.
EUVIMED